NAUT Nautilus Biotechnology, Inc.
$2.26 +3.67%
Healthcare · Laboratory Analytical Instruments
Nautilus Biotechnology, Inc. (NAUT) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $287 million. Shares last traded at $2.26, 47.3% below their 52-week high. Over the past year the stock is up 222.9%.
Market Cap
$287M
Shares Out
127.1M
EPS (TTM)
$-0.86
P/E Ratio
—
P/S Ratio
—
P/B Ratio
1.99
Dividend / Share
—
Dividend Yield
—
52-Week High
$4.29
52-Week Low
$0.63
Volume
22,323
Avg Vol (3m)
22,776.778
Performance
1W
-1.09%
1M
-4.44%
3M
-17.97%
6M
+24.52%
YTD
+18.95%
1Y
+222.86%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
40.59
SMA (50)
$2.65
SMA (200)
$2.09
Price vs SMA50
-14.70%
Price vs SMA200
+7.95%
ATR (14)
$0.16
Financials
Revenue
—
Net Income
$-59M
Gross Margin
—
Operating Margin
—
Net Margin
—
Return on Equity
-40.9%
Return on Assets
-33.2%
Current Ratio
11.85
Debt / Equity
0.23
Revenue Growth (YoY)
—
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $-0.12 | 2026-04-28 |
| FY 2025 | $-0.47 | 2026-02-26 |
| Q3 2025 | $-0.36 | 2025-10-28 |
| Q2 2025 | $-0.25 | 2025-07-31 |
| Q1 2026 | $-0.13 | 2026-04-28 |
| FY 2025 | $-0.56 | 2026-02-26 |
Laboratory Analytical Instruments peers
NAUT vs 14 industry peers (Laboratory Analytical Instruments), by market cap.
1–14 of 14
| A | Agilent Technologies | $35.9B | 27.55 | 5.17 | 18.8% | +2.23% |
| WAT | Waters Corporation | $34.9B | 54.32 | 11.03 | 20.3% | -0.44% |
| ILMN | Illumina, Inc. | $24.5B | 28.80 | 5.64 | 19.6% | +1.68% |
| MTD | Mettler Toledo | $23.1B | 26.59 | 5.74 | 21.6% | +1.22% |
| RVTY | Revvity | $11.1B | 46.22 | 3.90 | 8.4% | +2.23% |
| BRKR | Bruker Corp | $8.7B | -1049.06 | 2.53 | -0.2% | +4.51% |
| BIO | Bio-Rad Laboratories, Inc. | $7.6B | 10.02 | 2.95 | 29.4% | -0.80% |
| AVTR | Avantor, Inc. | $6.5B | -12.32 | 1.00 | -8.1% | +1.16% |
| TXG | 10x Genomics, Inc. | $4.5B | -102.51 | 6.94 | -6.8% | +8.24% |
| ALMR | Alamar Biosciences, Inc. | $1.5B | — | — | — | +8.56% |
| EYPT | Eyepoint, Inc. | $1.1B | -4.91 | — | — | +3.35% |
| CTKB | Cytek Biosciences, Inc. | $488M | -7.34 | 2.42 | -33.0% | -4.91% |
| PACB | Pacific Biosciences Of California, Inc. | $432M | -0.79 | — | — | +3.35% |
| LAB | STANDARD BIOTOOLS INC. | $324M | -4.32 | 3.79 | -87.8% | +2.65% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.